2025. Impact of thyroid immune-related adverse events on clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with checkpoint inhibitor therapy: A single center study. Biomolecules and Biomedicine. (Mar. 2025). DOI:https://doi.org/10.17305/bb.2025.12321.